论文部分内容阅读
目的评价经尿道前列腺电切气化术治疗前列腺增生的临床疗效和安全性。方法将我科就诊的132例良性前列腺增生患者随机分为观察组和对照组各66例,观察组予经尿道前列腺电切气化术治疗,对照组采用经尿道前列腺电切术治疗。记录全部患者的治疗过程和3个月随访情况,比较两组患者的疗效及安全性。结果全部患者均治愈出院,观察组术中出血量明显较对照组少,且住院时间更短;术后3个月随访,观察组的国际前列腺症状评分和最大尿流率均优于对照组,且剩余尿量更少,全部患者均无严重并发症发生。结论经尿道前列腺电切气化术安全性高,并发症少,较原技术有更为明确的疗效,是临床较好的治疗方案。
Objective To evaluate the clinical efficacy and safety of transurethral electrovaporization of the prostate in the treatment of benign prostatic hyperplasia. Methods A total of 132 patients with benign prostatic hyperplasia (BPH) treated in our department were randomly divided into observation group (66 cases) and control group (66 cases). The observation group was treated by transurethral electrovaporization of the prostate and the control group was treated by transurethral resection of the prostate. All patients were recorded during the course of treatment and 3-month follow-up, the efficacy and safety of two groups were compared. Results All the patients were cured and discharged. The bleeding volume in the observation group was significantly less than that in the control group and the hospitalization time was shorter. After 3 months of follow-up, the international prostate symptom scores and the maximum uroflow rate in the observation group were better than those in the control group, And the remaining urine less, no serious complications in all patients. Conclusions Transurethral electrotomy is safe and has fewer complications than the original technique. It is a better clinical treatment plan.